Brexit benefits Dundalk as Almac Group announce 100 new jobs for the town
Dundalk has seen the first major benefits of Brexit with the news that a Northern Ireland-based contract pharmaceutical development and manufacturing company is to create 100 new jobs in town.
Almac Group is making a multi-million euro investment in a new Dundalk premises at the IDA Business Park as it seeks to maintain access to the European Union market in the wake of Brexit.
The new plant will deliver 100 new jobs within the first two years, according to a statement on the company’s website. The group has about 3,000 employees in its headquarters in Criagavon.
“Almac’s decision to expand into Dundalk provides the company with certainty of access to the European Union in the long term – this certainty of access is an increaingly important selling point for Ireland as we look to win business,” said Martin Shanahan, chief executive of IDA Ireland, in the joint statement.
Welcoming the investment by Almac, Minister for Jobs, Enterprise and Innovation, Mary Mitchell O’Connor said: “This is a very exciting project for Dundalk and builds on the strong cluster of multinational companies who have very successfully located in that town in recent years and who have found it a great base from which to promote their sales into other EU Member States. Ireland’s expertise in the Pharma sector is unrivalled, with virtually all the major international players having operations here, thus generating synergies and opportunities for new companies investing with us. These additional 100 jobs to be provided are very welcome and we look forward to a long and mutually beneficial engagement with Almac into the future”.
The move comes in addition of addition to Armac’s recent announcement of a £27 million (€31.8 million) investment at its global headquarters in Craigavon, its US operations and European facility in Athlone, which stems from its acquisition of the Arran Chemical Company in 2015.